95. Autoimmune hepatitis Clinical trials / Disease details

Clinical trials : 52 / Drugs : 68 - (DrugBank : 28) / Drug target genes : 19 - Drug target pathways : 112

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-003381-14-SE (EUCTR)	19/02/2020	11/12/2019	Budesonide compared to prednisolone for the treatment of autoimmunehepatitis - A prospective randomized multicenter study	Budesonide versus Prednisolone as Primary Treatment for AutoimmuneHepatitis: An Open-label, Randomized, Prospective Multicenter 12-monthClinical Trial Evaluating Effect and Side-Effects. - AIHBUDPRED	Autoimmune hepatitis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]	Trade Name: Prednisolon Product Name: Prednisolon Trade Name: Budesonid Product Name: Various	Umeå University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	150	Phase 4	Sweden
2	NCT00587119 (ClinicalTrials.gov)	December 2007	21/12/2007	Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis	Open-Label Pilot Study Evaluating Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis.	Primary Biliary Cirrhosis;Autoimmune Hepatitis	Drug: Budesonide	Mayo Clinic	NULL	Withdrawn	21 Years	75 Years	Both	0	N/A	United States
3	NCT00838214 (ClinicalTrials.gov)	March 2001	5/2/2009	Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis	Efficacy and Safety of Budesonide Capsules (3x3mg/d)Versus Prednisone in Patients With a Diagnose of Active Autoimmune Hepatitis. A Double-blind, Randomized, Active-controlled, Multicentre Study	Autoimmune Hepatitis	Drug: budesonide;Drug: prednisone	Dr. Falk Pharma GmbH	NULL	Completed	10 Years	70 Years	All	208	Phase 2/Phase 3	Germany